LU84514A1 - Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone - Google Patents

Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone Download PDF

Info

Publication number
LU84514A1
LU84514A1 LU84514A LU84514A LU84514A1 LU 84514 A1 LU84514 A1 LU 84514A1 LU 84514 A LU84514 A LU 84514A LU 84514 A LU84514 A LU 84514A LU 84514 A1 LU84514 A1 LU 84514A1
Authority
LU
Luxembourg
Prior art keywords
weight
hydrocortisone
solution
composition according
composition
Prior art date
Application number
LU84514A
Other languages
English (en)
French (fr)
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Priority to LU84514A priority Critical patent/LU84514A1/fr
Priority to GB08332805A priority patent/GB2131693B/en
Priority to FR8319664A priority patent/FR2537438B1/fr
Priority to DE19833344437 priority patent/DE3344437A1/de
Priority to JP58230726A priority patent/JPS59112921A/ja
Priority to CH6582/83A priority patent/CH658191A5/fr
Priority to BE0/212016A priority patent/BE898417A/fr
Publication of LU84514A1 publication Critical patent/LU84514A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU84514A 1982-12-09 1982-12-09 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone LU84514A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
LU84514A LU84514A1 (fr) 1982-12-09 1982-12-09 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone
GB08332805A GB2131693B (en) 1982-12-09 1983-12-08 Composition for local corticotherapy containing hydrocortisone
FR8319664A FR2537438B1 (fr) 1982-12-09 1983-12-08 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone
DE19833344437 DE3344437A1 (de) 1982-12-09 1983-12-08 Stabiles, solubilisiertes hydrocortison enthaltendes mittel zur lokalen kortiko-therapie
JP58230726A JPS59112921A (ja) 1982-12-09 1983-12-08 局所皮膚治療用組成物
CH6582/83A CH658191A5 (fr) 1982-12-09 1983-12-08 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone.
BE0/212016A BE898417A (fr) 1982-12-09 1983-12-08 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU84514 1982-12-09
LU84514A LU84514A1 (fr) 1982-12-09 1982-12-09 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone

Publications (1)

Publication Number Publication Date
LU84514A1 true LU84514A1 (fr) 1984-10-22

Family

ID=19729991

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84514A LU84514A1 (fr) 1982-12-09 1982-12-09 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone

Country Status (7)

Country Link
JP (1) JPS59112921A (de)
BE (1) BE898417A (de)
CH (1) CH658191A5 (de)
DE (1) DE3344437A1 (de)
FR (1) FR2537438B1 (de)
GB (1) GB2131693B (de)
LU (1) LU84514A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004179A1 (en) * 1987-11-03 1989-05-18 Also Laboratori S.A.S. Pharmaceutical formulations for transdermal administration

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0978574A1 (de) * 1998-08-04 2000-02-09 Nalco Chemical Company Zusammensetzungen von kationische Tenside und deren Verwendung als verschmutzungsverhindernde Substanzen für Gebläse mit erzwungenen Abzug
US20060018852A1 (en) 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
US10851507B2 (en) 2017-12-11 2020-12-01 Pro-Tech Manufacturing And Distribution, Inc. Material pusher with floating coupler

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE673500C (de) * 1933-01-15 1939-03-23 Hoffmann La Roche & Co Akt Ges Verfahren zur Herstellung von haltbaren Loesungen schwer loeslicher Arzneimittel
NL6610468A (de) * 1965-08-03 1967-02-06
FR2314731A1 (fr) * 1975-06-19 1977-01-14 Nelson Res & Dev Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004179A1 (en) * 1987-11-03 1989-05-18 Also Laboratori S.A.S. Pharmaceutical formulations for transdermal administration

Also Published As

Publication number Publication date
GB2131693A (en) 1984-06-27
CH658191A5 (fr) 1986-10-31
JPS59112921A (ja) 1984-06-29
FR2537438A1 (fr) 1984-06-15
JPH034044B2 (de) 1991-01-22
DE3344437C2 (de) 1991-04-04
GB2131693B (en) 1986-07-02
FR2537438B1 (fr) 1985-11-22
DE3344437A1 (de) 1984-06-14
BE898417A (fr) 1984-06-08
GB8332805D0 (en) 1984-01-18

Similar Documents

Publication Publication Date Title
EP0841892B1 (de) Minoxidil enthaltendes haarpflegemittel mit einem niedrigen gehalt an fettigem lösungsmittel
EP0680745B1 (de) Verwendung von antimykotischen Mitteln und von halogenierten antibakteriellen Mitteln zur Verringerung des Haarausfalls
CH656532A5 (fr) Composition stable pour corticotherapie locale.
US5538720A (en) Hair treatment composition and process using metal salts
EP0719540B1 (de) Kosmetische oder dermatologische Wasser-in-Öl Emulsion mit hohem Gehalt an Hydroxysäuren
CA2062341C (fr) Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes
LU86256A1 (fr) Procede de teinture des fibres keratiniques avec du 5,6-dihydroxyindole associe avec un iodure
CH657987A5 (fr) Composition anti-acneique a base de peroxyde de benzoyle et d'au moins un autre principe actif.
LU86668A1 (fr) Procede de teinture des fibres keratiniques avec des derives d'indole associes avec un iodure
JP3462350B2 (ja) 毛髪処理用乳化物
FR2942716A1 (fr) Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
FR2613227A1 (fr) Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
LU86548A1 (fr) Composition sous forme de gel pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de piperidino-pyrimidine
LU84514A1 (fr) Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone
EP0835652B1 (de) Verwendung von mindestens einem Glykol zur Solubilisierung von Melatonin in Wasser und sie enthaltende Zusammensetzungen
LU86587A1 (fr) Dentifrice contenant un tensio-actif non ionique poly(hydroxypropylether)et un sel d'un derive specifique d'un produit de degradation des proteines
LU86396A1 (fr) Compositions pour le traitement de la calvitie et des alopecies
JP3537870B2 (ja) 発毛剤
JP3662494B2 (ja) 毛髪脱色剤組成物
EP0751759A1 (de) Haarpflegemittel enthaltend minoxidil
JP4610040B2 (ja) 育毛剤用添加剤及び育毛剤組成物
EP0795323A1 (de) Stabile gelifierte Zusammensetzung enthaltend sauerstoff- und/oder wasserempfindliche lipophile Prinzipien
JP3491027B2 (ja) 口腔用組成物
JP2869168B2 (ja) 育毛剤及びそれを含有する養毛化粧料
WO2005011566A2 (fr) Utilisation cosmetique d’un derive de biguanide en tant qu’actif anti-vieillissement de la peau